Low-cost, high-throughput quantitative phase microscopy

This project aims to develop a low-cost high-content screening platform using novel imaging technology to democratize access to advanced research tools in life sciences.

Subsidie
€ 150.000
2023

Projectdetails

Introduction

High-content screening is rapidly gaining traction across the biological sciences as a means to acquire more detailed data and test more hypotheses in an unprecedentedly rapid and systematic manner. However, a key issue identified by its users is that the instrumentation costs are too high, with systems typically costing from 150,000 to 800,000. This limits ownership of the instruments to well-funded research labs and, in doing so, excludes a significant portion of the multi-billion USD potential market. This project aims to target this unserved lower end of the market with a competitive high-content screening platform costing just 10,000.

Methodology

To achieve this, we will employ a novel quantitative phase imaging method originally developed for x-ray imaging as part of an ERC Starting Grant. The method allows us to make microscopes much simpler and less expensive without sacrificing image quality.

So far, we have successfully demonstrated that our new imaging approach is fast, robust, and can be readily utilized in such a low-cost screening system. Moreover, our IP is novel, protectable, and in the process of being patented.

Development Plan

This project will take the next steps towards commercialization by:

  1. Developing our prototype into a minimum viable product.
  2. Carrying out extensive research into the market and customer base to determine the optimum price point.
  3. Developing a field-tested sales pipeline and revenue model.
  4. Creating a robust business plan for the eventual spinout company.

Risk Assessment

Our decision to pursue the market for low-cost devices carries significant risk in that it necessitates high market penetration to achieve sufficient sales volume. However, should we successfully mitigate this risk (e.g., via focused development of the sales strategy), our endeavor will:

  • Eliminate the main entry barrier to high-throughput life science research.
  • Empower a new demographic of users with cutting-edge research tools.
  • Address the growing issue of inequality in research and healthcare.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 150.000
Totale projectbegroting€ 150.000

Tijdlijn

Startdatum1-1-2023
Einddatum30-6-2024
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • DANMARKS TEKNISKE UNIVERSITETpenvoerder
  • CLAIR SCIENTIFIC APS

Land(en)

Denmark

Vergelijkbare projecten binnen European Research Council

ERC Proof of...

Next-gen fluorescence imaging for research and theranostics

The project aims to develop the TriScanner, a novel fluorescence microscope that enhances imaging speed, resolution, and sensitivity for multicellular systems in research and clinical applications.

€ 150.000
ERC Proof of...

Fast and simple biomarker detection by computational microscopy

We developed a fast, sensitive biomarker detection method for early diagnosis and monitoring of cancer treatments, aiming to improve patient outcomes through preventative diagnostics.

€ 150.000
ERC Proof of...

Instrumented human stem cells to see more during high throughput screening in drugInstrumented human stem cells to see more during high throughput screening in drug discovery and regenerative medicine

The hiPSCmore project aims to engineer fluorescent sensors in human induced pluripotent stem cells to reduce costs and enhance high-throughput imaging for drug discovery and regenerative medicine.

€ 150.000
ERC Consolid...

Advanced X-ray Energy-sensitive Microscopy for Virtual Histology

This project aims to develop a prototype phase-contrast micro-CT scanner for non-invasive 3D histology to enhance volumetric analysis of tissue samples, particularly lung lesions.

€ 2.000.000
ERC Proof of...

Multiplexed microRNA detection platform for early diagnosis and patient management

The MiRACLE project aims to develop a cost-effective diagnostic platform for early disease detection by utilizing a novel optical sensing method to simultaneously detect individual micro-RNA molecules in bodily fluids.

€ 150.000

Vergelijkbare projecten uit andere regelingen

Mkb-innovati...

High Throughput Cell contractility system for rapid drug evaluation

Cytocypher en Optics11 ontwikkelen samen een prototype van een high throughput screening systeem voor het functioneel meten van hartspiercellen, ter bevordering van cardiologisch onderzoek.

€ 193.900
EIC Transition

Photonic chip based high-throughput, multi-modal and scalable optical nanoscopy platform

NanoVision aims to revolutionize optical nanoscopy with an affordable, compact, and high-throughput photonic-chip solution, enhancing accessibility and flexibility for research and clinical labs.

€ 2.489.571
EIC Transition

Revolutionizing Spatial Biology with a cutting-edge Multi-Scale Imaging platform

The NanoSCAN project aims to develop the SAFe-nSCAN platform for high-resolution 3D tissue analysis, enhancing molecular profiling and advancing personalized therapies in immuno-oncology.

€ 2.489.162
Mkb-innovati...

BORSTKANKERDETECTIE D.M.V. CAMERATECHNOLOGIEËN/ ARTIFICIËLE INTELLIGENTIE

Sigmascreening onderzoekt de haalbaarheid van een innovatief product voor borstkankerdetectie met 3D-camera's en AI, gericht op toegankelijkheid en marktbehoefte.

€ 20.000
EIC Pathfinder

On-chip tomographic microscopy: a paraDIgm Shift for RevolUtionizing lab-on-a-chiP bioimaging technology

DISRUPT aims to revolutionize biomedical imaging with a novel lab-on-chip technology for cost-effective, high-resolution cancer detection and diagnostics using integrated tomographic microscopy and AI.

€ 3.018.312